FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990068981> ?p ?o ?g. }

• W1990068981 endingPage "1609" @default.
• W1990068981 startingPage "1607" @default.
• W1990068981 abstract "OBJECTIVE To evaluate the prostate‐specific antigen (PSA) ‘flare’ phenomenon in patients with androgen‐independent prostate cancer (AIPC) treated with docetaxel, as flare is a known effect of androgen‐deprivation therapy in hormone‐dependent prostate cancer. PATIENTS AND METHODS The charts of 56 patients who received docetaxel‐based chemotherapy in three different centres from August 1999 to August 2007 were reviewed retrospectively. The biochemical response was characterized according to the Bubley criteria. There was an immediate PSA response (PSA decline ≥ 50%) in 23 (41%) patients, PSA stabilization (PSA decline < 50%) in 16 (29%) and PSA progression in nine (16%). There was also a fourth response, i.e. PSA flare, defined as an increase in PSA level with no symptomatic progression, after starting docetaxel‐based chemotherapy administered every 3 weeks. RESULTS Eight (14%) patients with PSA flare were identified; all had osseous disease and five had additional soft‐tissue disease. The PSA flare lasted a median (range) of 21 (21–42) days and it spread over a median of 1 (1–2) cycles. The temporary PSA surge exceeded baseline values by a median (range) of 61.5 (12–404)%. There was a subsequent PSA response in six of the eight patients and PSA stabilized in the remaining two. Patients with flare received a median of 8.5 (5–12) treatment cycles, vs a median of 8 (2–12) in the immediate PSA response group ( P = 0.103, Student’s t ‐test). The Response Evaluation Criteria in Solid Tumors criteria evaluation showed one patient with a partial response and six with stable disease. The median survival of patients with PSA flare was 12.5 months, while that of the immediate PSA responders was 20.1 months (not statistically significant, P = 0.168, log‐rank test). CONCLUSION Of patients with AIPC, 14% had an initial PSA flare after starting docetaxel‐based chemotherapy. The occurrence of PSA flare had no effect on treatment duration or outcome. With lack of clinical progression, docetaxel‐based chemotherapy should be administered for at least two 3‐week cycles before further decisions are made about efficacy." @default.
• W1990068981 created "2016-06-24" @default.
• W1990068981 creator A5004985848 @default.
• W1990068981 creator A5009846091 @default.
• W1990068981 creator A5066728112 @default.
• W1990068981 creator A5078851457 @default.
• W1990068981 date "2008-11-21" @default.
• W1990068981 modified "2023-10-17" @default.
• W1990068981 title "Prostate-specific antigen flare phenomenon with docetaxel-based chemotherapy in patients with androgen-independent prostate cancer" @default.
• W1990068981 cites W1488048258 @default.
• W1990068981 cites W1972418094 @default.
• W1990068981 cites W1979001077 @default.
• W1990068981 cites W2000984979 @default.
• W1990068981 cites W2008408544 @default.
• W1990068981 cites W2019230861 @default.
• W1990068981 cites W2023275561 @default.
• W1990068981 cites W2028743669 @default.
• W1990068981 cites W2035267333 @default.
• W1990068981 cites W2045686027 @default.
• W1990068981 cites W2080439368 @default.
• W1990068981 cites W2120292596 @default.
• W1990068981 cites W2129994890 @default.
• W1990068981 cites W2139248078 @default.
• W1990068981 cites W2155679349 @default.
• W1990068981 cites W2155839539 @default.
• W1990068981 cites W2167331614 @default.
• W1990068981 cites W2171858932 @default.
• W1990068981 cites W2607028219 @default.
• W1990068981 doi "https://doi.org/10.1111/j.1464-410x.2008.07873.x" @default.
• W1990068981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18990177" @default.
• W1990068981 hasPublicationYear "2008" @default.
• W1990068981 type Work @default.
• W1990068981 sameAs 1990068981 @default.
• W1990068981 citedByCount "28" @default.
• W1990068981 countsByYear W19900689812012 @default.
• W1990068981 countsByYear W19900689812013 @default.
• W1990068981 countsByYear W19900689812014 @default.
• W1990068981 countsByYear W19900689812015 @default.
• W1990068981 countsByYear W19900689812016 @default.
• W1990068981 countsByYear W19900689812017 @default.
• W1990068981 countsByYear W19900689812018 @default.
• W1990068981 countsByYear W19900689812019 @default.
• W1990068981 countsByYear W19900689812020 @default.
• W1990068981 countsByYear W19900689812021 @default.
• W1990068981 countsByYear W19900689812022 @default.
• W1990068981 countsByYear W19900689812023 @default.
• W1990068981 crossrefType "journal-article" @default.
• W1990068981 hasAuthorship W1990068981A5004985848 @default.
• W1990068981 hasAuthorship W1990068981A5009846091 @default.
• W1990068981 hasAuthorship W1990068981A5066728112 @default.
• W1990068981 hasAuthorship W1990068981A5078851457 @default.
• W1990068981 hasConcept C121608353 @default.
• W1990068981 hasConcept C126322002 @default.
• W1990068981 hasConcept C126894567 @default.
• W1990068981 hasConcept C143998085 @default.
• W1990068981 hasConcept C2776694085 @default.
• W1990068981 hasConcept C2777899217 @default.
• W1990068981 hasConcept C2780192828 @default.
• W1990068981 hasConcept C2781190966 @default.
• W1990068981 hasConcept C2781406297 @default.
• W1990068981 hasConcept C71924100 @default.
• W1990068981 hasConceptScore W1990068981C121608353 @default.
• W1990068981 hasConceptScore W1990068981C126322002 @default.
• W1990068981 hasConceptScore W1990068981C126894567 @default.
• W1990068981 hasConceptScore W1990068981C143998085 @default.
• W1990068981 hasConceptScore W1990068981C2776694085 @default.
• W1990068981 hasConceptScore W1990068981C2777899217 @default.
• W1990068981 hasConceptScore W1990068981C2780192828 @default.
• W1990068981 hasConceptScore W1990068981C2781190966 @default.
• W1990068981 hasConceptScore W1990068981C2781406297 @default.
• W1990068981 hasConceptScore W1990068981C71924100 @default.
• W1990068981 hasIssue "11" @default.
• W1990068981 hasLocation W19900689811 @default.
• W1990068981 hasLocation W19900689812 @default.
• W1990068981 hasOpenAccess W1990068981 @default.
• W1990068981 hasPrimaryLocation W19900689811 @default.
• W1990068981 hasRelatedWork W1963763301 @default.
• W1990068981 hasRelatedWork W2035098213 @default.
• W1990068981 hasRelatedWork W2522846761 @default.
• W1990068981 hasRelatedWork W2728894889 @default.
• W1990068981 hasRelatedWork W2753537866 @default.
• W1990068981 hasRelatedWork W2896276799 @default.
• W1990068981 hasRelatedWork W2915731681 @default.
• W1990068981 hasRelatedWork W3111778365 @default.
• W1990068981 hasRelatedWork W4200552296 @default.
• W1990068981 hasRelatedWork W4240979600 @default.
• W1990068981 hasVolume "102" @default.
• W1990068981 isParatext "false" @default.
• W1990068981 isRetracted "false" @default.
• W1990068981 magId "1990068981" @default.
• W1990068981 workType "article" @default.